Role of nonsteroidal anti-inflammatory drugs on change in macular volume postcataract surgery in diabetic eyes: A retrospective comparative study
- PMID: 39132110
- PMCID: PMC11309548
- DOI: 10.4103/ojo.ojo_26_23
Role of nonsteroidal anti-inflammatory drugs on change in macular volume postcataract surgery in diabetic eyes: A retrospective comparative study
Abstract
Context: Diabetic eyes suffer from variety of complications including macular edema. Cataract surgery is the most commonly done procedure throughout the world and majority would be diabetics. As pseudophakic-cystoid macular edema (CME) is a known complication following cataract surgery, our study concentrated on finding the role of prophylactic topical nonsteroidal anti-inflammatory drugs (NSAIDs) on change in total macular volume (TMV) postcataract surgery in diabetic eyes.
Aims: To evaluate the role of NSAIDs on change in TMV postcataract surgery in diabetic eyes.
Settings and design: Retrospective comparative study.
Subjects and methods: Data were collected from the medical records department of our institute constituting diabetics undergoing cataract surgery from June-2021 to February-2022. Eighty diabetic eyes were divided into two groups: one group were given topical nepafenac drops and another who were not given. Demographic details, diabetic retinopathy stage, preoperative optical coherence tomography (OCT), and postoperative day (POD) 7, day 28, and 3 months OCT were collected. Statistical analysis was done to compare the change in TMV between both the groups.
Statistical analysis used: Student's t-test and Chi-squared/Fisher's exact test were employed to find statistically significant differences between the two groups using SPSS-22.0 software.
Results: In our study, the mean age in the group with nepafenac was 60.93 ± 5.86 years and 31 (77.5%) had moderate nonproliferative diabetic retinopathy (NPDR), and in the group without nepafenac, the mean age was 58.53 ± 7.41 years and 30 (75%) had moderate NPDR. Majority of the individuals in the study group were known diabetic for 2-5 years. Change in TMV at POD 3 months among two groups was not statistically significant; P = 0.758 (P < 0.05-significant).
Conclusions: Our study concluded that topical-NSAIDs played no role in postoperative period following cataract surgery with respect to change in TMV in diabetic eyes. Thus, prophylactic usage of topical-NSAIDs can be a burden on patient as it has no role in prevention of pseudophakic-CME in those with the duration of diabetes mellitus <5 years and with mild-to-moderate NPDR.
Keywords: Nonsteroidal anti-inflammatory drugs; pseudophakic cystoid macular edema; total macular volume.
Copyright: © 2024 Oman Ophthalmic Society.
Conflict of interest statement
There are no conflicts of interest.
Figures


Similar articles
-
Impact of topical nonsteroidal anti-inflammatory drugs in prevention of macular edema following cataract surgery in diabetic patients.Int J Ophthalmol. 2018 Apr 18;11(4):616-622. doi: 10.18240/ijo.2018.04.13. eCollection 2018. Int J Ophthalmol. 2018. PMID: 29675380 Free PMC article.
-
New observation of microcystic macular edema as a mild form of cystoid macular lesions after standard phacoemulsification: Prevalence and risk factors.Medicine (Baltimore). 2018 Apr;97(15):e0355. doi: 10.1097/MD.0000000000010355. Medicine (Baltimore). 2018. PMID: 29642179 Free PMC article.
-
Prophylaxis of macular edema after cataract surgery in diabetic patients, topical Nepafenac versus intravitreal Ranibizumab.Eur J Ophthalmol. 2022 Jan;32(1):205-212. doi: 10.1177/11206721211001275. Epub 2021 Mar 16. Eur J Ophthalmol. 2022. PMID: 33726537 Clinical Trial.
-
[Studies on clinical pathophysiology of pseudophakic/aphakic eyes--a journey of 4 decades].Nippon Ganka Gakkai Zasshi. 2008 Mar;112(3):214-45; discussion 246. Nippon Ganka Gakkai Zasshi. 2008. PMID: 18411712 Review. Japanese.
-
Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives.Clin Ophthalmol. 2017 Dec 11;11:2183-2190. doi: 10.2147/OPTH.S132810. eCollection 2017. Clin Ophthalmol. 2017. PMID: 29269999 Free PMC article. Review.
Cited by
-
Prophylactic topical nepafenac in preventing postoperative macular edema.Oman J Ophthalmol. 2025 Feb 25;18(1):104-105. doi: 10.4103/ojo.ojo_341_24. eCollection 2025 Jan-Apr. Oman J Ophthalmol. 2025. PMID: 40124448 Free PMC article. No abstract available.
References
-
- Entezari M, Ramezani A, Nikkhah H, Yaseri M. The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: A randomized controlled trial. Int Ophthalmol. 2017;37:13–8. - PubMed
-
- Stock RA, Galvan DK, Godoy R, Bonamigo EL. Comparison of macular thickness by optical coherence tomography measurements after uneventful phacoemulsification using ketorolac tromethamine, nepafenac, versus a control group, preoperatively and postoperatively. Clin Ophthalmol. 2018;12:607–11. - PMC - PubMed
-
- Salmon JF. Kanski’s Clinical Ophthalmology – A Systematic Approach. 9th. China: Elsevier; 2020. Acquired macular disorders; p. 606.
-
- Kessel L, Tendal B, Jørgensen KJ, Erngaard D, Flesner P, Andresen JL, et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: A systematic review. Ophthalmology. 2014;121:1915–24. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials